VistaGen Therapeutics
VTGN
$4.60
Share price
-0.32%
Change (1 day)
3,442.31%
Change (1 year)
Categories
VistaGen Therapeutics (VTGN) - Total assets
Total assets on the balance sheet as of December 2023 : $0.13 B
According to VistaGen Therapeutics 's latest financial reports the company's total assets are $0.13 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
VistaGen Therapeutics - Total assets on balance sheet (from 2008 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-03-31 | $21.08 M | -71.75% |
| 2022-03-31 | $74.64 M | -31.07% |
| 2021-03-31 | $0.10 B | 1775.88% |
| 2020-03-31 | $5.77 M | -58.8% |
| 2019-03-31 | $14.01 M | 24.24% |
| 2018-03-31 | $11.27 M | 203.82% |
| 2017-03-31 | $3.71 M | 275.05% |
| 2016-03-31 | $0.98 M | 267% |
| 2015-03-31 | $0.26 M | 2.28% |
| 2014-03-31 | $0.26 M | -70.09% |
| 2013-03-31 | $0.88 M | 158.05% |
| 2012-03-31 | $0.34 M | |
| 2010-12-31 | $0 M | 59.88% |
| 2009-12-31 | $0 M | -94.03% |
| 2008-12-31 | $0.02 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | 92.27% | 🇺🇸 USA |